{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:19:14Z","timestamp":1788452354021,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clinre.2026.102819","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T23:27:48Z","timestamp":1774826868000},"page":"102819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pancreatic neuroendocrine tumors: A narrative review"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3532-8263","authenticated-orcid":false,"given":"Sarita","family":"Velasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6506-9485","authenticated-orcid":false,"given":"Manuelita","family":"Pardo-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul Antonio","family":"Ca\u00f1adas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Rojas-Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Parra-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2026.102819_bib0001","series-title":"Endotext","article-title":"Pathophysiology and Treatment of Pancreatic Neuroendocrine Neoplasms (PNENS): new developments","year":"2000"},{"issue":"10","key":"10.1016\/j.clinre.2026.102819_bib0002","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.clinre.2026.102819_bib0003","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/oncolo\/oyac049","article-title":"Survival and incidence patterns of pancreatic neuroendocrine tumors over the last 2 decades: a SEER database analysis","volume":"27","author":"Sonbol","year":"2022","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.clinre.2026.102819_bib0004","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/annonc\/mdv505","article-title":"Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis","volume":"27","author":"Leoncini","year":"2016","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.clinre.2026.102819_bib0005","first-page":"210","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"67","author":"Dasari","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.clinre.2026.102819_bib0006","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-07-0750","article-title":"Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study","volume":"17","author":"Hassan","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.clinre.2026.102819_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.21037\/gs.2017.10.08","article-title":"Management of functional neuroendocrine tumors of the pancreas","volume":"7","author":"\u00d6berg","year":"2018","journal-title":"Gland Surg"},{"issue":"3","key":"10.1016\/j.clinre.2026.102819_bib0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1200\/JCO.2012.44.2905","article-title":"Circulating tumor cells as prognostic markers in neuroendocrine tumors","volume":"31","author":"Khan","year":"2013","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.clinre.2026.102819_bib0008","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3748\/wjg.v26.i19.2305","article-title":"Pancreatic neuroendocrine tumors: a review of serum biomarkers, staging, and management","volume":"26","author":"Ma","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2026.102819_bib0009","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1186\/s12885-020-07356-5","article-title":"World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution","volume":"20","author":"Yang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clinre.2026.102819_bib0029","series-title":"Endocrine and neuroendocrine tumours","year":"2022"},{"issue":"12","key":"10.1016\/j.clinre.2026.102819_bib0020","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13343","article-title":"European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours","volume":"35","author":"Kos-Kud\u0142a","year":"2023","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"10.1016\/j.clinre.2026.102819_bib0011","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.suc.2019.04.014","article-title":"Evaluation and management of neuroendocrine tumors of the pancreas","volume":"99","author":"Scott","year":"2019","journal-title":"Surg Clin North Am"},{"issue":"4","key":"10.1016\/j.clinre.2026.102819_bib0012","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/ERC-15-0092","article-title":"Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status","volume":"22","author":"Kidd","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.clinre.2026.102819_bib0013","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2217\/ije.14.40","article-title":"Imaging in neuroendocrine tumors: an update for the clinician","volume":"2","author":"Maxwell","year":"2015","journal-title":"Int J Endocr Oncol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102819_bib0017","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1159\/000503721","article-title":"Neuroendocrine neoplasms of the small bowel and pancreas","volume":"110","author":"Clift","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"11","key":"10.1016\/j.clinre.2026.102819_bib0016","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1007\/s00261-018-1574-4","article-title":"Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance","volume":"43","author":"Lee","year":"2018","journal-title":"Abdom Radiol"},{"issue":"3","key":"10.1016\/j.clinre.2026.102819_bib0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1200\/JCO.2016.67.8193","article-title":"Modified staging classification for pancreatic neuroendocrine tumors on the basis of the AJCC and ENETS systems","volume":"35","author":"Luo","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clinre.2026.102819_bib0018","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.suc.2019.04.014","article-title":"Evaluation and management of neuroendocrine tumors of the pancreas","volume":"99","author":"Scott","year":"2019","journal-title":"Surg Clin North Am"},{"issue":"12","key":"10.1016\/j.clinre.2026.102819_bib0021","doi-asserted-by":"crossref","first-page":"E1759","DOI":"10.1055\/a-1261-9605","article-title":"Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a systematic review of the literature","volume":"08","author":"Imperatore","year":"2020","journal-title":"Endosc Int Open"},{"issue":"1","key":"10.1016\/j.clinre.2026.102819_bib0022","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.surg.2018.04.070","article-title":"Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs)","volume":"165","author":"Scott","year":"2019","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.clinre.2026.102819_bib0024","first-page":"35","article-title":"systemic treatment of metastatic pancreatic and gastrointestinal neuroendocrine tumors","volume":"5","author":"Serrano","year":"2015","journal-title":"Country Clin Med J"},{"issue":"3","key":"10.1016\/j.clinre.2026.102819_bib0025","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.clinre.2026.102819_bib0027","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1158\/1078-0432.CCR-16-2743","article-title":"Long-term efficacy, survival, and safety of [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors","volume":"23","author":"Brabander","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.clinre.2026.102819_bib0028","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12020-013-0130-9","article-title":"Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors","volume":"47","author":"Fiore","year":"2014","journal-title":"Endocrine"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:40:55Z","timestamp":1788450055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2210740126000665"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102819","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatic neuroendocrine tumors: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102819"}}